ATARA BIOTHERAPEUTICS INC stock forecast: up to 3.58 USD ATRA stock price prognosis
Forecast for Fri 19 May 2023 price
ATARA BIOTHERAPEUTICS INC stock price forecast for further price development up to 20.27% (time horizon: 1 day) and price target of 3.58 USD. Short-term (time horizon: 2 weeks) ATARA BIOTHERAPEUTICS INC share price prediction for 2023-05-19 with daily closed price projections
On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.
Summerized Form 10-K with GPT-2
Atara is applying this one platform to create a robust pipeline. This ORR is consistent with previously published investigator assessed data. We anticipate potential approval of the MAA in the second half of 2022. Data from this Phase 2 study is expected in 2023. Some preclinical testing may continue even after the IND is submitted. In such a case, the clinical trial cannot be conducted in that Member State. We do not expect to generate product revenues in the near future, if at all. Our company was formed in August 2012. Product defects can also occur unexpectedly. As a result, the government has certain rights to these patent rights and technology. We may not be able to protect our intellectual property rights throughout the world. There are currently no FDA- or EMA-approved products for the treatment of EBV+ PTLD. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. As of December 31, 2020, we had 437 employees. These market fluctuations may adversely affect the trading price of our common stock. We generally contract with third parties for the disposal of these materials and wastes. The CCPA may increase our compliance costs and potential liability. Such notice could harm our reputation and our ability to compete. Where state laws are more protective, we have to comply with the stricter provisions.
Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.
Meta analyst score 56.42/100
Good financial position.
Historical view, profit is growing.
Company revenue is not growing faster compared with the
Stock price is under book price value.
Institutional ownership list is based on filling form information
Bollinger Bollinger Bands for ATARA BIOTHERAPEUTICS INC can provide the information where the market is moving based on price information.
ATARA BIOTHERAPEUTICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.
Converting prices to returns ATARA BIOTHERAPEUTICS INC.
On-Balance Volume information for ATARA BIOTHERAPEUTICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.
Accumulation / Distribution (A/D) indicator information for ATARA BIOTHERAPEUTICS INC. The indicator identify divergences between price and volume flow.
Aroon Oscillator information for ATARA BIOTHERAPEUTICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.
Average Directional Index (ADX) information for ATARA BIOTHERAPEUTICS INC. The index can be used to identify the strengh of a trend.
Moving Average Convergence Divergence (MACD) for ATARA BIOTHERAPEUTICS INC. The indicator helps to predict trend direction and the momentum of the trend.
Stochastic Oscillator as momentum indicator for ATARA BIOTHERAPEUTICS INC. The indicator is useful for identifying overbought and oversold levels.
Relative Strength Index (RSI) for ATARA BIOTHERAPEUTICS INC. RSI is a momentum oscillator that measures the speed and change of price development.
The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period.
Primary usage of the indicator is to identify overbought or oversold signals.
When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30
Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio
The forecast (dashed curve) of the share price performance is based on historical data.
Our forecast model is based on mathematical, statistical methods.
The website offers price forecasts and analysis tools for equities and other securities,
which are exclusively based on the prices of these securities in the past.
Information about these prices is provided to us by third parties. Although we believe,
If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and
correct sequencing of this information.
We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider
any financial data or other data of such issuers with the exception of the past prices of the securities.
Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or
that may be relevant for future security price flows. Investments require additional considerations.
Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor
or the tax implications an investment may have for the investor. Although we believe that
our mathematical models are a tool to try to explore the possibility for future price development
with the help of past performance, such developments are subject to a multitude of different influences.
and therefore not really predictable.
We cannot guarantee the success of any investment you make based on the information published here.
This website is for information purposes only. All information and data on this website cannot be guaranteed
to be accurate,
accuracy, completeness and appropriateness - neither explicit nor implicit.